Nefrologia

The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Kidney international. 2026 Mar; 109(Mar):442-464. doi: 10.1016/j.kint.2025.09.019. pii: S0085-2538(25)00774-4.

KDIGO 2026 clinical practice guideline for Anemia in Chronic Kidney Disease (CKD): a commentary from the European Renal Best Practice (ERBP).

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2026 Jan; doi: 10.1093/ndt/gfag014. pii: gfag014.

Podocyte Metabolic Reprogramming and Targeted Therapy.

Journal of the American Society of Nephrology : JASN. 2026 Mar; 37(Mar):619-633. doi: 10.1681/ASN.0000000917. pii: .

Management of monoclonal gammopathy of renal significance: treatment standard.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2026 Feb; 41(Feb):445-456. doi: 10.1093/ndt/gfaf254. pii: .

More than a Last Resort: The Role of Tunneled Catheters in Hemodialysis.

Clinical journal of the American Society of Nephrology : CJASN. 2026 Mar; 21(Mar):526-528. doi: 10.2215/CJN.0000000852. pii: .

Amino acid metabolism in diabetic kidney disease.

Clinical and experimental nephrology. 2026 Mar; 30(Mar):373-377. doi: 10.1007/s10157-025-02809-2. pii: .

"A Change Is Gonna Come" to Treatment of Lupus Nephritis: A Review.

American journal of kidney diseases : the official journal of the National Kidney Foundation. 2026 Mar; 87(Mar):422-432. doi: 10.1053/j.ajkd.2025.08.016. pii: S0272-6386(25)01144-8.

Complement Inhibition in Immunoglobulin A Nephropathy: A Mini-Review.

American journal of kidney diseases : the official journal of the National Kidney Foundation. 2026 Mar; 87(Mar):412-421. doi: 10.1053/j.ajkd.2025.07.023. pii: S0272-6386(25)01211-9.

IgA Nephropathy in Adults: A Review.

JAMA. 2026 Mar; 335(Mar):799-813. doi: 10.1001/jama.2025.25020. pii: .

GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease.

Nature reviews. Nephrology. 2026 Apr; 22(Apr):265-282. doi: 10.1038/s41581-025-01036-y. pii: .

Autosomal dominant polycystic kidney disease.

Lancet (London, England). 2026 Mar; 407(Mar):1289-1302. doi: 10.1016/S0140-6736(26)00046-2. pii: S0140-6736(26)00046-2.

Liver Transplantation in Alcohol-Related Liver Disease.

The New England journal of medicine. 2026 Apr; 394(Apr):1341-1344. doi: 10.1056/NEJMclde2506067. pii: .

The Roller Coaster Ride of IgA Nephropathy.

American journal of kidney diseases : the official journal of the National Kidney Foundation. 2026 Mar; doi: 10.1053/j.ajkd.2025.10.019. pii: S0272-6386(26)00041-7.

Chronic kidney disease.

Lancet (London, England). 2026 Jan; 407(Jan):90-104. doi: 10.1016/S0140-6736(25)01942-7. pii: S0140-6736(25)01942-7.

A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury: The Liberation From Acute Dialysis (LIBERATE-D) Randomized Clinical Trial.

JAMA. 2026 Jan; 335(Jan):326-335. doi: 10.1001/jama.2025.21530. pii: .

Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial.

The New England journal of medicine. 2026 Feb; 394(Feb):635-646. doi: 10.1056/NEJMoa2512133. pii: .

Validation of the Klinrisk Machine Learning Model for CKD Progression in a Large Representative US Population.

Journal of the American Society of Nephrology : JASN. 2026 Feb; 37(Feb):326-337. doi: 10.1681/ASN.0000000817. pii: .

RNA-based therapeutic opportunities for the treatment of kidney diseases.

Nature reviews. Nephrology. 2026 Jan; 22(Jan):12-29. doi: 10.1038/s41581-025-01011-7. pii: .

Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD).

Kidney international. 2026 Jan; 109(Jan):44-56. doi: 10.1016/j.kint.2025.06.005. pii: S0085-2538(25)00494-6.

Renal Pathology Society/International Kidney and Monoclonal Gammopathy Research Group consensus on pathologic definitions and terminology of monoclonal gammopathy-associated kidney lesions.

Kidney international. 2025 Aug; 108(Aug):184-193. doi: 10.1016/j.kint.2025.04.007. pii: S0085-2538(25)00336-9.

KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD).

Kidney international. 2026 Jan; 109(Jan):S1-S99. doi: 10.1016/j.kint.2025.06.006. pii: S0085-2538(25)00495-8.

KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV).

Kidney international. 2025 Oct; 108(Oct):S1-S71. doi: 10.1016/j.kint.2025.04.004. pii: S0085-2538(25)00279-0.

S.E.N., SLANH, and SEEDO consensus report on obesity-related kidney disease: proposal for a new classification.

Kidney international. 2025 Oct; 108(Oct):572-583. doi: 10.1016/j.kint.2025.06.013. pii: S0085-2538(25)00505-8.

Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV).

Kidney international. 2025 Oct; 108(Oct):548-554. doi: 10.1016/j.kint.2025.04.003. pii: S0085-2538(25)00278-9.

Chronic Kidney Disease of unexplained cause (CKDx): a consensus statement by the Genes & Kidney Working Group of the ERA.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2025 Nov; 40(Nov):2390-2400. doi: 10.1093/ndt/gfaf092. pii: .

KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children.

Kidney international. 2025 May; 107(May):S241-S289. doi: 10.1016/j.kint.2024.11.007. pii: S0085-2538(24)00797-X.

Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2024 Clinical Practice Guideline.

Annals of internal medicine. 2025 May; 178(May):705-713. doi: 10.7326/ANNALS-24-01926. pii: .

Management of genetically determined kidney stone disease: consensus from a panel of urologists and nephrologists.

Minerva urology and nephrology. 2025 Feb; 77(Feb):130-136. doi: 10.23736/S2724-6051.24.05875-0. pii: .

KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Kidney international. 2025 Feb; 107(Feb):S1-S239. doi: 10.1016/j.kint.2024.07.009. pii: S0085-2538(24)00479-4.

I Brazilian guideline on hypertension in dialysis of the Brazilian Society of Nephrology.

Jornal brasileiro de nefrologia. 2025 ; 47():e20240033. doi: 10.1590/2175-8239-JBN-2024-0033en. pii: e20240033.

Recommendations for diagnosis and treatment of Atypical Hemolytic Uremic Syndrome (aHUS): an expert consensus statement from the Rare Diseases Committee of the Brazilian Society of Nephrology (COMDORA-SBN).

Jornal brasileiro de nefrologia. 2025 ; 47():e20240087. doi: 10.1590/2175-8239-JBN-2024-0087en. pii: e20240087.

Diagnosis and management of immune checkpoint inhibitor-associated nephrotoxicity: a position statement from the American Society of Onco-nephrology.

Kidney international. 2025 Jan; 107(Jan):21-32. doi: 10.1016/j.kint.2024.09.017. pii: S0085-2538(24)00724-5.

Light-chain (AL) amyloidosis for nephrologists-treatment standard.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2024 Dec; 40(Dec):34-47. doi: 10.1093/ndt/gfae224. pii: .

Hyponatraemia-treatment standard 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2024 Sep; 39(Sep):1583-1592. doi: 10.1093/ndt/gfae162. pii: .

Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a clinical practice document by the European Renal Best Practice board of the European Renal Association.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2024 Sep; 39(Sep):1710-1730. doi: 10.1093/ndt/gfae075. pii: .

Clinical practice guideline for the prevention and management of peritoneal dialysis associated infections in children: 2024 update.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 2024 Sep; 44(Sep):303-364. doi: 10.1177/08968608241274096. pii: .

Iohexol plasma clearance measurement protocol standardization for adults: a consensus paper of the European Kidney Function Consortium.

Kidney international. 2024 Oct; 106(Oct):583-596. doi: 10.1016/j.kint.2024.06.029. pii: S0085-2538(24)00537-4.

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline.

BMJ (Clinical research ed.). 2024 Oct; 387(Oct):e080257. doi: 10.1136/bmj-2024-080257. pii: .

Clinical guideline on adequacy and prescription of peritoneal dialysis.

Nefrologia. 2024 Sep; 44 Suppl 1(Sep):1-27. doi: 10.1016/j.nefroe.2024.09.001. pii: S2013-2514(24)00172-X.

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.

Kidney international. 2024 Apr; 105(Apr):S117-S314. doi: 10.1016/j.kint.2023.10.018. pii: S0085-2538(23)00766-4.

Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns.

Kidney international. 2024 Apr; 105(Apr):684-701. doi: 10.1016/j.kint.2023.10.016. pii: S0085-2538(23)00764-0.

KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis.

Kidney international. 2024 Mar; 105(Mar):S71-S116. doi: 10.1016/j.kint.2023.10.008. pii: S0085-2538(23)00744-5.

KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS.

Kidney international. 2024 Jan; 105(Jan):S1-S69. doi: 10.1016/j.kint.2023.09.002. pii: S0085-2538(23)00627-0.

Liver Transplantation in Alcohol-Related Liver Disease.

The New England journal of medicine. 2026 Apr; 394(Apr):1341-1344. doi: 10.1056/NEJMclde2506067. pii: .

GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease.

Nature reviews. Nephrology. 2026 Apr; 22(Apr):265-282. doi: 10.1038/s41581-025-01036-y. pii: .

Autosomal dominant polycystic kidney disease.

Lancet (London, England). 2026 Mar; 407(Mar):1289-1302. doi: 10.1016/S0140-6736(26)00046-2. pii: S0140-6736(26)00046-2.

The Roller Coaster Ride of IgA Nephropathy.

American journal of kidney diseases : the official journal of the National Kidney Foundation. 2026 Mar; doi: 10.1053/j.ajkd.2025.10.019. pii: S0272-6386(26)00041-7.

Finerenone in Type 1 Diabetes and Chronic Kidney Disease.

The New England journal of medicine. 2026 Mar; 394(Mar):947-957. doi: 10.1056/NEJMoa2512854. pii: .

IgA Nephropathy in Adults: A Review.

JAMA. 2026 Mar; 335(Mar):799-813. doi: 10.1001/jama.2025.25020. pii: .

Complement Inhibition in Immunoglobulin A Nephropathy: A Mini-Review.

American journal of kidney diseases : the official journal of the National Kidney Foundation. 2026 Mar; 87(Mar):412-421. doi: 10.1053/j.ajkd.2025.07.023. pii: S0272-6386(25)01211-9.

Podocyte Metabolic Reprogramming and Targeted Therapy.

Journal of the American Society of Nephrology : JASN. 2026 Mar; 37(Mar):619-633. doi: 10.1681/ASN.0000000917. pii: .

Amino acid metabolism in diabetic kidney disease.

Clinical and experimental nephrology. 2026 Mar; 30(Mar):373-377. doi: 10.1007/s10157-025-02809-2. pii: .

More than a Last Resort: The Role of Tunneled Catheters in Hemodialysis.

Clinical journal of the American Society of Nephrology : CJASN. 2026 Mar; 21(Mar):526-528. doi: 10.2215/CJN.0000000852. pii: .